Verikai

Verikai Inc.Founded in 2018, Verikai Inc. is based in San Francisco, US, and focuses on transforming healthcare data into actionable insights.Verikai offers advanced risk assessment solutions designed to transform data into actionable healthcare insights, focusing on the integration of medical, pharmaceutical, and lifestyle data. Their core product offerings, including Capture®Lifestyle, Capture®Health, and Capture®360, utilize advanced analytics and machine learning to predict health risks, ultimately aiding insurance underwriters in making informed decisions. These solutions cater to a diverse client base, including insurance companies that handle fully insured, stop-loss, and level-funded health plans. Verikai's products are primarily utilized across the United States, where they are implemented to enhance underwriting processes and optimize risk assessments by enabling clients to navigate potential health risks with precision.Verikai's revenue model is built upon providing subscription-based access to its suite of risk assessment tools and analytics services. Clients, primarily in the insurance sector, engage in partnerships to leverage Verikai’s proprietary data and insights, enhancing their underwriting capabilities. The transaction structure typically involves contractual agreements for access to the Capture® suite, wherein clients pay fees for ongoing support, updates, and system integration services. This model facilitates a steady revenue stream as clients rely on Verikai's innovative solutions for critical decision-making processes., though specific financial terms were not disclosed. The company aims to enhance its product offerings, focusing on new features for its Capture® suite set to launch within the next year. Additionally, Verikai is exploring expansion opportunities into new geographic markets, with plans to reach additional regions in North America by 2024.

1. Series A

   Mar 31, 2020

   Amount

   $6.9M

   Investors

   Locked